P59 Quantitative measurement of EGFR is a predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer
Rydén L, Giltnane J, Cregger M, Jirström K, Bendahl P, Rimm D. P59 Quantitative measurement of EGFR is a predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer. The Breast 2007, 16: s29. DOI: 10.1016/s0960-9776(07)70124-8.Peer-Reviewed Original ResearchHormone receptor-positive premenopausal breast cancerPremenopausal breast cancerTamoxifen responsePredictive factorsBreast cancerCancerEGFR